CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
Conditions
- Metastatic Castration-Resistant Prostate Cancer
- Ovarian Cancer
- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer
- Other Solid Tumor
Interventions
Sponsor
pharmaand GmbH